Lysophosphatidic acid increases soluble ST2 expression in mouse lung and human bronchial epithelial cells

Cell Signal. 2012 Jan;24(1):77-85. doi: 10.1016/j.cellsig.2011.08.004. Epub 2011 Aug 17.

Abstract

Lysophosphatidic acid (LPA), a naturally occurring bioactive lysophospholipid increases the expression of both pro-inflammatory and anti-inflammatory mediators in airway epithelial cells. Soluble ST2 (sST2), an anti-inflammatory mediator, has been known to function as a decoy receptor of interleukin (IL)-33 and attenuates endotoxin-induced inflammatory responses. Here, we show that LPA increased sST2 mRNA expression and protein release in a dose and time dependent manner in human bronchial epithelial cells (HBEpCs). LPA receptors antagonist and Gαi inhibitor, pertussis toxin, attenuated LPA-induced sST2 release. Inhibition of NF-κB or JNK pathway reduced LPA-induced sST2 release. LPA treatment decreased histone deacetylase 3 (HDAC3) expression and enhanced acetylation of histone H3 at lysine 9 that binds to the sST2 promoter region. Furthermore, limitation of intracellular LPA generation by the down-regulation of acetyl glycerol kinase attenuated exogenous LPA-induced histone H3 acetylation on sST2 promoter region, as well as sST2 gene expression. Treatment of HBEpCs with recombinant sST2 protein or sST2-rich cell culture media attenuated endotoxin-induced phosphorylation of PKC and airway epithelial barrier disruption. These results unravel a novel sST2 mediated signaling pathway that has physiological relevance to airway inflammation and remodeling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Animals
  • Base Sequence
  • Bronchi / cytology*
  • Cell Line
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Gene Knockdown Techniques
  • Histone Acetyltransferases / metabolism
  • Histones / metabolism
  • Humans
  • Interleukin-1 Receptor-Like 1 Protein
  • Lung / cytology
  • Lung / drug effects
  • Lung / metabolism*
  • Lysophospholipids / metabolism
  • Lysophospholipids / pharmacology
  • Lysophospholipids / physiology*
  • Mice
  • Molecular Sequence Data
  • NF-kappa B / metabolism
  • Phosphorylation
  • Phosphotransferases (Alcohol Group Acceptor) / genetics
  • Phosphotransferases (Alcohol Group Acceptor) / metabolism
  • Promoter Regions, Genetic
  • Protein Kinase C / metabolism
  • RNA Interference
  • Receptors, Cell Surface / genetics
  • Receptors, Cell Surface / metabolism*
  • Receptors, Lysophosphatidic Acid / agonists
  • Receptors, Lysophosphatidic Acid / metabolism
  • Respiratory Mucosa / cytology
  • Respiratory Mucosa / drug effects
  • Respiratory Mucosa / metabolism*
  • Sequence Analysis, DNA
  • Signal Transduction
  • Transcription Factor AP-1 / metabolism
  • Transcription, Genetic

Substances

  • Histones
  • IL1RL1 protein, human
  • Interleukin-1 Receptor-Like 1 Protein
  • Lysophospholipids
  • NF-kappa B
  • Receptors, Cell Surface
  • Receptors, Lysophosphatidic Acid
  • Transcription Factor AP-1
  • Histone Acetyltransferases
  • AGK protein, human
  • Phosphotransferases (Alcohol Group Acceptor)
  • Protein Kinase C
  • lysophosphatidic acid